Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efalizumab vs Cyclosporine in De Novo Renal Transplantation
NCT00729768Phase 3Withdrawn
- Sponsor
- Genentech
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
01
Overview
A Phase 3 trial of efalizumab in kidney transplantation, sponsored by Genentech. Status: withdrawn.
02
Drugs
efalizumab
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT00729768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00729768.